Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma

NCT01677468 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hallym University Medical Center